1. The fate of [14C]amphetamine in man, rhesus monkey, greyhound, rat, rabbit, mouse and guinea pig has been studied. 2. In three men receiving orally 5mg each (about 0.07mg/kg), about 90% of the 14C was excreted in the urine in 3-4 days.
( i) -2-Amino -1 -(4'-hydroxy-3'-methoxyphenyl)propane.
Vanillin benzyl ether (60g) (Spith, Orechoff & Kuffner, 1934) , nitroethane (25g), piperidine (1.9ml) and butylamine (1.25ml) in benzene (125ml) were refluxed for 40h, a Dean-Stark trap being used to remove the water formed. The mixture was washed with M-HCI (2 x 200ml) and then water (3 x 200ml) . The benzene layer was dried over anhydrous Na2SO4 and the solvent removed under reduced pressure. Recrystallization of the residue from ether-benzene (8:1, v/v) (450ml) gave yellow crystals (33g) of 1-(4'-benzyloxy-3'-methoxyphenyl)-2-nitroprop-1-ene, m.p.91°C [Fodor (1943) gives m.p.92°C). This (29.9g) was reduced with LiAlH4 (11.4g) in ether (500ml) in a Soxhlet apparatus. When the mixture became colourless (4h), it was cooled and treated with water. 2M-NaOH was added to dissolve insoluble material and the ether layer was separated and evaporated. The residue was taken up in , made alkaline with 2.5M-NaOH and extracted with ether (200ml). The extract was evaporated to an oil, which solidified overnight at 000. This solid (15g) in acetic acid (225ml) was treated for 10min with lOM-HCI (52ml) and the whole heated for 1 h at 1000C. It was then evaporated to dryness in vacuo and the solid recrystallized from aq. ethanol to give (+ ) -2-amino -1 -(4'-hydroxy -3'-methoxyphenyl)propane hydrochloride [3.7g; ] as white needles [Robinson, Lowe & Imperial Chemical Industries Ltd. (1940) give m.p. 254-255°C (decomp.) ].
(± )-2-Amino-1-(3',4'-dimethoxyphenyl)propane. The hydrochloride of this compound was prepared as above starting with veratraldehyde (42g), nitroethane (24ml), piperidine (1.9ml) and butylamine (1.25ml). The yield was 3.8g of hydrochloride, m.p. 1440C (cf. Mannich & Jacobsohn, 1910) .
( +)-2-Amino-1-(4'-hydroxyphenyl)propan-1-ol. To a solution of p-benzyloxypropiophenone (48g; Spath et al. 1934) in methylene dichloride (250ml), solid CaCO3 (25g) was added. The mixture was heated under reflux with stirring and bromine (10.25 ml) was added dropwise over 1.5 h to keep the mixture a pale yellow. After cooling, 2m-HCI was added to dissolve insoluble material, and the methylene dichloride layer was separated, washed with NaHCO3 (5%; 125ml) and then water (2xlOOml) and dried over anhydrous Na2SO4. Evaporation of the solvent in vacuo gave an oil, which crystallized at'0°C. Recrystallization from ethanol gave white platelets of (+)-1-(4'-benzyloxyphenyl)-2-bromopropan-1-one (24g) m.p.77-78°C (Found; 0, 60.2; H, 4.7; Br, 25.3 ; C16H,5BrO2 requires C, 60.2; H, 4.7; Br, 25.0%).
To a solution of the above ketone (16 g) in warm ethanol (100ml), dibenzylamine (19.9g) was added during 10min and the solution refluxed with stirring for 4.5h. After keeping at room temperature overnight, excess of dibenzylamine hydrochloride was filtered off, washed with ether and the washings were added to the filtrate. The latter was evaporated in vacuo to a yellow solid, which was extracted with ether. The ethereal solution was washed with water, dried over anhydrous Na2SO4 and evaporated to dryness. The yellow solid was recrystallized from methanol (300ml) to give white rhombic plates (23g) of 1-(4'-benzyloxyphenyl)-2 -(NN-dibenzylamino)propan-lone, m.p. 82.4; H, 6.7; N, 3.35%; C30H29NO2 requires C, 82.7; H, 6.7; N, 3.2%) .
The above compound (8g) in warm ethanol (5Oml) was neutralized with dry ethanolic HCI. 3g) was added and the mixture hydrogenated at 601b/in2 for 13h. After filtration, the solution was evaporated in vacuo and the resulting oil taken up in acetone and neutralized with ethanolic HCI. The (25, 4Ci; 30mg) in water. The 24h urine (100ml) was mixed with an equal volume of lOM-HCI and heated under reflux for 2h. 1-Phenylpropan-2-one (3 ml) was added to the cooled solution and the whole extracted with ether (3x50ml). The extract was washed with 2% NaHCO3 solution (2x50ml) followed by water (2 x 50ml) and then evaporated at 200C. The residue was treated with excess of sodium bisulphite solution (4.5g in 17ml of aq. 30% ethanol). After 30min the bisulphite compound of 1-phenylpropan-2-one (2.6g) that had separated was filtered, washed with a little water followed by ethanol and ether and sucked dry. It was then stirred into 2m-NaOH (20ml), and the ketone that separated was taken up in ether (50ml). The ether solution was washed with water, dried over anhydrous Na2SO4 and evaporated to a pale-yellow liquid (0.76ml). The 1-phenyl[1-14C]propan-2-one had a specific radioactvity of 2,tCi/g. H, 5.8; N, 4.0; C23H21NO3 requires C, 76.9; H, 5.9; N, 3.9%) .
Di-and tri-benzoyl derivativeB of 4-hydroxynorephedrine. (± )-2-Amino-1-(4'-hydroxyphenyl)propan-1-ol hydrochloride (0.3g) in 2.5M-NaOH (5ml) was treated with benzoyl chloride (1.5ml) at room temperature. After shaking for 5min, the precipitate that formed was collected and washed with water. The solid was recrystallized from the minimum volume of aq. 80% ethanol to give 2 -benzamido-1 -(4'-benzoyloxyphenyl) - Hippuric acid. The carrier (1 g) was dissolved in urine, solution being assisted by addition of a little 40% NaOH. The urine was adjusted to pH2 and extracted with ethyl acetate (3 x 100ml). The extract was evaporated and the residue of hippuric acid recrystallized (m.p. 187°C) from hot water to constant specific radioactivity. In calculation of the amount of hippuric acid derived from amphetamine, allowance was made for the endogenous acid in the urine, which was determined fluorimetrically (Ellman, Burkhalter & La Dou, 1961 ).
1-Phenylpropan-2-one. The ketone (1g) was added to urine or acid-hydrolysed urine (see as described above for amphetamine), solution being assisted by the addition of a little ethanol. The ketone was then extracted with ether (3 x 100ml) and the extract evaporated. The residue in ethanol (5ml) was heated on a water bath for 15min with a solution of semicarbazide hydrochloride (1 g) and anhydrous sodium acetate (0.9g) in water (5ml). The semicarbazone of the ketone was filtered, washed with water and recrystallized (m.p. 19400) from ethanol to constant specific radioactivity.
1-Phenylpropan-2-ol. The (± )-carbinol (1g) was added to untreated or acid-or enzyme-hydrolysed urine. To obtain the last-mentioned urine, a suitable volume of urine was brought to pH5 with acetic acid and then incubated for 24 h with an equal volume of ,-glucuronidase solution (Ketodase; Warner-Chilcott, Morris Plains, N.J., U.S.A.). The carbinol was extracted with ether (3 x 100ml) and the extract dried over anhydrous Na2SO4 and evaporated in vacuo. The residue in light petroleum (b.p. 100-120°C) (lOml) was treated with phenyl isocyanate (1.2ml) and the mixture was refluxed on a boiling-water bath for 2h and then filtered hot. The phenylurethane of the carbinol separated on cooling and was recrystallized (m.p.89°C) from light petroleum (b.p. 100120oC) to constant specific radioactivity. 427 Vol. 116 2-Amino-1-phenylpropanol. (i)-Norephedrine hydrochloride (1.235g) was dissolved in urine, which was then adjusted to pH12 with lOM-NaOH and extracted with ether (3 x 100 ml). The residue from evaporation of the extract was treated with 3M-NaOH (lOml) and acetic anhydride (3ml), and the mixture was shaken and kept at 00C overnight. 2-Acetamido-l-phenylpropan-l-ol separated and was recrystallized (m.p.133°C) from an ethyl acetate-hexane mixture to constant specific radioactivity.
2-Amino-1-(4'-hydroxyphenyl)propan-1-ol. The urine was mixed with an equal volume of lOm-HCl and then heated at 1000C for 2h. The carrier [0.304g of (± )-4-hydroxynorephedrine hydrochloride] was added and the mixture made just alkaline with 10% NaOH. This solution (10-15ml) was now made alkaline with 10% NaOH (5ml), and benzoyl chloride (1.5ml) was added. The mixture was shaken for 5min, and the precipitate that formed was filtered and the 2-benzamido-1-benzoyloxy (4'-benzoyloxyphenyl)-1-propane, m.p. 181-182°C, recrystallized to constant specific radioactivity from aq. 80% ethanol.
Isotope-dilution procedures were also carried out on the rat or rabbit urine with 2-methylamino-1-phenylpropane (hydrochloride, m.p. 1320C, from ethanol-ether), (± None of these compounds entrained radioactivity when added to the urine and reisolated.
Chromatography
The RF values and colour reactions of the compounds relevant to this study are given in Table 1. Precursor of 1 -phenylpropan-2-one l-Phenylpropan-2-one was found in the acid-hydrolysed urine of men, dogs and rabbits receiving amphetamine but not in the unhydrolysed urine. In rabbit urine the ketone appeared as an acid-labile precursor, X, showing RF 0.60 in solvent B and RF 0.33 in solvent C (Table 1) . About 20% of the dose of [14C]amphetamine appeared as compound X in rabbit urine (see Table 6 ) and about 1-7 % probably as compound X in human and dog urine (see Tables 3 and 6 ). On chromatograms, compound X gave no positive colour reactions for glycine, glucuronic acid, acetylcysteine or glutathione (Knight & Young, 1958) conjugates, nor did it give the ninhydrin reaction. Suitable incubations of the urine, voided after dosing of rabbits with ['4C]amphetamine, with ,-glucuronidase (Ketodase) or limpet arylsulphatase (sulphatase; Sigma Chemical Co., St Louis, Mo., U.S.A.) did not appear to cause hydrolysis of compound X. When the urine was kept overnight at 1800 with an equal volume of m-NaOH or m-HCI and then chromatographed and the strips examined in the radiochromatogram scanner, compound X was found to have disappeared and had not been replaced by a new radioactive peak. It thus appeared that compound X was converted by dilute acid or alkali into a product volatile under the conditions of the experiment.
Attempted isolation of compound X. Three rabbits (body wt. 3kg) were each given daily for 3 days 25mg of (± )-amphetamine/kg orally. For location of compound X by radiochromatogram scanning, their urine (900ml) was mixed with urine (lOOml) from a rabbit that had received similarly 20,uCi of [14C]amphetamine. The mixed urine was filtered through glass wool and then freeze-dried. The residue was extracted with 95% ethanol (4 x 100ml), and the extract filtered and evaporated in vacuo to 20ml. The solids, mainly urea, were filtered off and the filtrate usedforpreparativet.l.c. Portions (0.5 ml each) of the filtrate were applied to 20 alumina plates (aluminium oxide-G; E. Merck A.-G., Darmstadt, Germany; 20cm x 20cm x 1mm thick), which were developed with pyridine-pentan-1-ol-water (7:7:6, by vol). The position of compound X was determined by scanning a suitable plate (5 cm x 20 cm by 1mm thick) developed at the same time. The band with RF 0.7-0.8 was scraped off the plates and compound X was eluted with aq. 90% ethanol. The eluates were evaporated in vacuo to 11 ml, which was applied to five t.l.c. plates (2ml each) prepared as above. The plates were developed with solvent C (Table 1) , in which compound X was found to have RF 0.2-0.3. The appropriate area was scraped from the plates and eluted with aq. 90% ethanol. The eluates were filtered and evaporated to 1 ml, which was again chromatographed on a t.l.c. plate with the first solvent (pyridine-pentan-l-olwater) as above. Compound X was again eluted with aq. 90% ethanol, and the eluate was evaporated to 1 ml, which was then freeze-dried to a pale-yellow solid (about 20mg).
Hydrolysis of compound X. The solid (4mg) in 5M-HCI (3 ml) was heated under refilux at 1000C for 2h and after cooling part of the hydrolysate (2.5ml) was warmed with 2,4-dinitrophenylhydrazine (5mg) in ethanol (lml) . The precipitate that formed on cooling was filtered, washed with water and recrystallized from ethanol to give deepyellow platelets of the 2,4-dinitrophenylhydrazone of 1-phenylpropan-2-one, m.p. and mixed m.p.152-153oC.
In ethanol, the crystals showed light-absorption at A.,1. 360nm and~260nm, the known values found for the authentic compound (El Masry, Smith & Williams, 1956 ). The rest of the hydrolysate (0.5ml) was diluted with ethanol and the solution showed light-absorption with Ama1. 260nm and -285nm. In ethanol the ketone shows Amax. 260nm (ma,. 249) and -285nm (ma. 156) (Kumler, Strait & Alpen, 1950) .
Another sample was hydrolysed as above and the hydrolysate examined in the amino acid auto-analyser (Locarte) . Traces of glycine, arginine and cysteic acid were found, but in amounts that suggested that they were impurities. A sodium fusion test on compound X showed the presence of sulphur but not of nitrogen. When a small sample of compound X was warmed with 5m-HCl followed by a few drops of BaCl2 solution a white precipitate formed, suggesting the presence of sulphate. At this point it appeared that compound X contained sulphate 1970 428 Table 1 . RF values and colour reactions of amphetamine and related compounds Descending chromatography on Whatman no. 1 paper was used. The solvent systems employed were: A, butan-l-ol-aq. 2% (w/v) citric acid (1:1, v/v) ; in this case the paper had been previously dipped in aq. 5% sodium dihydrogen citrate and then dried (Curry & Powell, 1954) ; B, butan-l-ol saturated with 1.5M-ammoniaammonium carbonate buffer (Fewster & Hall, 1951) ; C, 3-methylbutan-1-ol-2-methylbutan-2-ol-waterformic acid (5:5:10:2, by vol.) (Alleva, 1963) ; D, butan-l-ol-toluene-acetic acid-water (2:2:1:1, by vol.). Chromatograms were run until the front had travelled 35cm from the origin. The diazotized nitroaniline spray was used as described by Wichstrom & Salversen (1952) Williams, 1965) and hippuric acid with p-dimethylaminobenzaldehyde (Gaffney, Schreier, DiFerrante & Altman, 1954) .
RF value
Compound Amphetamine N-Methylamphetamine N-Acetylamphetamine 4-Hydroxyamphetamine 4-Methoxyamphetamine Norephedrine 4-Hydroxynorephedrine 2-Amino-1-(3',4'-dihydroxyphenyl)propane 2-Amino-1-(4'-hydroxy-3'-methoxyphenyl)- Pale pink Green None None None associated in some way with l-phenylpropan-2-one. Since 1-phenylpropan-2-one is reported to occur to the extent of about 2.9% in the enol form (Gero, 1954) , i.e. 1-phenylprop-l-en-2-ol, it was possible that compound X might be l-phenylprop-l-en-2-yl hydrogen sulphate. Formation of compound X from 1-phenylpropan-2-one in rabbits. I-Phenyl[1_14C]propan-2-one (2g; 1.1 pCi) was fed to a doe rabbit (3 kg) and a 72h urine sample was collected. Of the administered 14C, 91% was excreted in 24h and a further 3% during the next 2 days. Samples (0.1 ml) of the 24h urine were chromatographed on Whatman no. 1 paper strips with solvent B or C (Table 1) . The strips were cut into 1.5cm pieces and their radioactivity was determined in the scintillation spectrometer. Four radioactive peaks were found as follows ( positive naphtharesorcinol test for glucuronides. The first peak after acid hydrolysis (5m-HCI) also gave a positive ferric chloride test for a phenol. The first peak could thus be a glucuronide of a phenol derived from l-phenylpropan-2-one, and the second peak a glucuronide of 1-phenylpropan-2-ol; such a glucuronide is a known metabolite of the ketone (El Masry et al. 1956 ). The third peak was identified by colour reactions as hippuric acid, also a known metabolite of the ketone. The fourth peak (RF 0.58 in solvent B and RF 0.26 in solvent C) corresponded to metabolite X of amphetamine urine.
An isotope dilution for I-phenylpropan-2-one on a sample ofthe urine showed that none ofthe original ketone was present. However, aft%r acid hydrolysis (with an equal volume of 1OM-HCI for 2h at 100°C under reflux), isotope dilution showed that 14.9% ofthe dose was present as the ketone.
Injection of inorganic [35S]sulphate.
A rabbit was injected intraperitoneally with 250,uCi of Na235SO4 (The Radiochemical Centre, Amersham, Bucks., U.K.) in 0.5ml of water and the 24h urine collected for use as a control. The next day the rabbit was given another injection of the same amount of Na235S04 followed 1 h later by an oral dose (2g) of 1-phenylpropan-2-one. The urine (65ml) was collected for the next 24h. Samples (0.01 ml) of both urines were chromatographed on paper strips (Watman no. 1) in solvents B and C. After development and drying, the strips were scanned for 35S. A portion (2ml) of the urine after treatment with Na235SO4 and the ketone was streaked across Whatman 3MM paper (39.7 cmx 42.3 cm) and chromatographed in solvent C. The paper was dried and a suitable strip of it scanned to locate metabolite X, which was then eluted with 95% ethanol. Some of the eluate was then chromatographed on an alumina plate, when it showed a single Vol. 116 429 tl spot, RF 0.18 in solvent C and RF 0.7 in pyridine-pentan-1-ol-water (7:7:6, by vol.). The ethanol eluate was evaporated to dryness, the residue dissolved in water (1 ml) and the solution treated with 10% Ba(NO3)2 (1 ml) and 10% Na2SO4 (1 ml). The precipitated BaSO4 was centrifuged and washed twice with water, but was found to contain no 35S. The supernatant was mixed with an equal volume of lOM-HCI and heated under reflux for 2h. The cooled solution was extracted with ether and then the ether carefully evaporated. The residue was treated with 2,4-dinitrophenylhydrazine (10mg) in ethanol (1 ml) and lOM-HCI (0.05ml). The mixture was extracted with CHC13 (25 ml) andthe extract washed with 2M-HCI (2 x 10 ml). The CHC13 was removed and the residue taken up in ethanol. The absorption spectrum of this solution showed
Ama.. 360nm and -260nm, which corresponds to that of the 2,4-dinitrophenylhydrazone of 1-phenyl-propan-2-one. The supernatant left after ether extraction was now treated with carrier 10% Na2SO4 (1 ml) and 10% Ba(NO3)2 (1 ml) as before. The precipitate of BaSO4 was found to contain 35S with a specific radioactivity of 2,uCi/g. Separation of the basic metabolites. The 24 h urine of rats given orally (± )-[14C]amphetamine sulphate (10mg/kg; 5,Ci/rat) was collected. The urine (5 ml) was brought to pH5 with 2M-acetio acid and incubated at 370C for 24h with 5ml of ,-glucuronidase solution (Ketodase; Warner-Chilcott Laboratories). With phenolphthalein glueuronide as a control. The solution was then adjusted to pH6 with M-ammonia, and 0.5mg each of (± )-amphetamine, (± )-norephedrine, (± )-4-hydroxyamphetamine and (±) -4 -hydroxynorephedrine was added. It was then passed through a column (1cm x 11 cm) of the acid form of IRC-50 resin (standard grade) (recycled as described by Hirs, Moore & Stein, 1953) at the rate of 4ml/h. The column was then washed with water (20ml) and eluted with 2M-HCI (40ml). The eluate was freeze-dried and the residue extracted with ethanol (2ml) and portions (0.05-0.2ml) of the extract were chromatographed on Whatman no. 1 paper with solvent D (Table 1 ). The basic metabolites on the chromatogram were detected by radiochromatogram scanning (see Table 1 for RF values and colour reaction).
RESULTS
Man. The results for three male subjects are shown in Tables 2 and 3 . In man, the 14C is excreted largely (about 90%) in the urine, about 60% (35, 23, 32) of the dose being excreted in the first 24h. There was little difference in 14C excretion after administration of the three optical forms of amphetamine (Table 2) . On examination of the first 24h urine by isotope dilution, the main radioactive excretory product is amphetamine, amounting to about 30-35% of the dose or about one-half of the 24h 140 excretion, irrespective of the isomer given (Table 3) . Table 3 gives the individual results for the three subjects, and it will be noted that subject G.D. is excreting less amphetamine and more p-hydroxyamphetamine than the other two. The significance, if any, of these differences is not clear. The other major metabolite is benzoic acid and its conjugates, which amount to about 20% of the dose for the (±)-and (+)-isomers and rather less (about 13%) for the (-)-isomer. Human urine also contains a substance that yields 1-phenylpropan-2-one on acid hydrolysis. The amount of this substance is small (1-3%), but the third subject (S.F.) is producing more than the other two from all three forms of the drug. Rhesus monkey. Two female monkeys were used (Tables 4 and 5 ) and were given the labelled (+)-and (-)-isomer. Both isomers appeared to be treated similarly, but one monkey excreted the 14C more rapidly than the other (Table 4 ). The composition of the 24h urine of these monkeys is shown in Table 5 . The main metabolites are benzoic acid and its conjugates, and possibly less benzoic acid is produced from the (-)-than from the (+)-isomer. 4-Hydroxyamphetamine is a minor metabolite, although monkey no. 1 produced no hydroxyamphetamine from the (+)-isomer. Unchanged amphetamine is a major excretory product except in monkey no. 1 receiving (+)-amphetamine.
Monkey urine did not contain a precursor of 1-phenylpropan-2-one.
Rat. In this species some 90% of the 14C of each of the three isomers can be accounted for in 3 days, largely in the urine (Table 4 ). The main metabolite of amphetamine in the rat is 4-hydroxyamphetamine, which amounts to about 60% of the dose in 2 days for the (±)-and (-)-isomers and about 50% for the (+)-isomer (Table 6 ). The hydroxy compound is excreted largely as a conjugate that appears, from chromatographic studies before and after treatment of the urine with f-glucuronidase, to be a glucuronide. Benzoic acid and its conjugates are minor metabolites (about 2-3%), and amphetamine itself amounts to about 10-20%, its excretion being essentially the same for the three isomers. A precursor of I-phenylpropan-2-one did not occur in rat urine and a number of other possible metabolites of amphetamine were absent.
The basic metabolites in rat urine were examined in detail in separate experiments. The chromatograms of the basic metabolites on being scanned for radioactivity showed five peaks of RF 0.10, 0.30, 0.44, 0.57 and 0.98. The large peaks at RF 0.30 and 0.57 were identified as 4-hydroxyamphetamine and amphetamine respectively. The minor peaks at RF 0.10 and 0.44 corresponded to norephedrine and 4-hydroxynorephedrine (see Table 1 ). Their identity and amount were determined by isotope dilution (Table 1) , and it corresponded to N-acetylamphetamine in amounts of about 1-2% of the dose ( Table  6 shows that 2% of the amphetamine excreted by the rat is in a combined form). Identification of N-acetylamphetamine has not been confirmed, since the compound showed no colour reactions and its melting point, which we found to be 66-67°C (see Hey, 1930) after long desiccation, was unreliable for isotope dilution.
Rats receiving [14C]amphetamine were also kept in a chamber suitable for collecting expired air. No radioactive CO2 was detected in the expired air in two separate experiments.
Mouse. In the mouse, over 80% of the 14C is excreted in the urine (Table 4) . But the mouse differs from the rat in that 4-hydroxyamphetamine is not the major metabolite in the urine, although it is present in appreciable amounts (10-19%) compared with other species. In the mouse, the main excretory products are amphetamine (about 30%) and benzoic acid and its conjugates (about 30%).
Mouse urine, like that of the rat, contains no precursor of 1-phenylpropan-2-one (Table 6) .
Guinea pig. In the guinea pig, the major metabolites are benzoic acid and its conjugates, which amount to 60-70% of the dose (Table 6) . No 4-hydroxyamphetamine is formed from the (+)-isomer, but about 1% (conjugated) is formed from the (-)-isomer. Amphetamine itself is also excreted, more of the (+)-isomer (22%) being excreted unchanged than the (-)-isomer (15%); possibly the (-)-isomer is metabolized more readily in this animal than the (+)-isomer. The guinea pig did not excrete a precursor of 1-phenylpropan-2-one.
Rabbit. The metabolism of (+)-amphetamine in the rabbit differs from that in most of the other species (Table 6 ). There is little unchanged amphetamine (3%) or 4-hydroxyamphetamine (6%) excreted. The main metabolites are benzoic acid and its conjugates (25%) and a precursor of 1-phenylpropan-2-one (22%) (see below). Some conjugated 1-phenylpropan-2-ol (7%) is also excreted.
Greyhound. The excretory products of (±)-amphetamine are very similar to those found in man (Table 6 ).
DISCUSSION
The quantitative aspects of the main metabolites of amphetamine in the urine of various species are summarized in Table 7 , in which the metabolites of (+)-or (+)-amphetamine are compared. This seems permissible, since the quantitative differences in the metabolism of the optical forms are not very marked within a species. Table 7 shows that there are considerable species differences in the metabolism of amphetamine, but it must be kept in mind that man and the rhesus monkey received much smaller doses than the other four species.
Man, monkey and dog appear to metabolize the drug in an approximately similar manner. In these species, about half of the excreted drug is unchanged. Although N-methyl-and N-acetylamphetamine are possible metabolites, chromato--graphic studies suggested that they were probably absent from the urine of these species. An isotope dilution for N-methylamphetamine in human urine Vol. 116 433 gave a negative result. Amphetamine was 4-hydroxylated to a minor extent (1-6%). The major transformation product in these species was benzoic acid and its conjugates. A precursor of 1-phenylpropan-2-one was found in small amounts in human and dog urine, but not in monkey urine. The four other species (Table 7) , which received comparable doses, differ from one another and from man, monkey and dog. In the rat, the major metabolite in the urine is 4-hydroxyamphetamine conjugated with glucuronic acid. Aromatic hydroxylation is thus the major metabolic reaction of the drug in the rat, while deamination and oxidation to benzoic acid are relatively minor. Rats also excrete some unchanged amphetamine (11%) together with what appears chromatographically to be N-acetylamphetamine (about 2%). The rat produced no I-phenylpropan-2-one precursor. It has been reported that (+)-amphetamine [but not the (-)-isomer] and 4-hydroxyamphetamine are substrates for dopamine (3,4-dihydroxyphenethylamine) ,-hydroxylase of ox adrenal glands (Goldstein & Contrera, 1962; Goldstein, McKereghan & Lauber, 1964) , and Sjoerdsma & von Studnitz (1963) have shown that 4-hydroxyamphetamnine is converted to a small extent in man into 4-hydroxynorephedrine, a reaction that also occurs in mice (Iversen, Glowinski & Axelrod, 1966) . The rat urine was therefore examined by isotope dilution for the products of the hydroxylation of the methylene group ofamphetamine and its 4-hydroxy derivative. Small amounts of conjugated 2-amino-1-phenylpropan-l-ol (norephedrine) (0.3% of the dose in each of two rats) and of 2-amino-1-(4'-hydroxyphenyl)propan-I-ol (4-hydroxynorephedrine) (0.3 % in one rat) were found.
In the guinea pig, the metabolism of amphetamine appears to be relatively simple. The major route of metabolism leads to benzoic acid and its conjugates. About 22% of the drug is excreted unchanged. Hydroxylation does not occur to any appreciable extent with the (+)-isomer, but about 1% of the (-)-isomer was hydroxylated. There appears to be no 1-phenylpropan-2-one precursor.
The metabolism of amphetamine in the mouse might be expected to be similar to the rat, but Table 7 shows that this is not so. There is a high excretion ofunchanged amphetamine and ofbenzoic acid, both of which are excreted in low amounts in the rat. Although the mouse is a better hydroxylator of amphetamine than the other species except the rat, the extent of hydroxylation is only about one-quarter of that in the rat.
The rabbit appears to be unique among the species studied, since it excretes little unchanged amphetamine or 4-hydroxyamphetamine. The major route of metabolism is by deamination, leading to 1-phenylpropan-2-one and the corresponding carbinol, and benzoic acid. The ketone was not found as such in the urine, but as an acid-labile precursor, compound-X. The latter was not isolated in a pure form, but it was shown to contain 1-phenylpropan-2-one and sulphate. The report in the literature (Gero, 1954) that the ketone occurs to a small extent in the enol form suggests that X might be a salt of I-phenylprop-l-en-2-yl hydrogen sulphate, C6H5 *.CH:C(0.*803H) .0CH3.
The n.m.r. spectrum of compound X in D20 was consistent with the structure C65 0 CH0: C 0CH3, the X-values being 2.66, 2.76 (phenyl), 2.55 (C0) and 7.6 (CH3) and the corresponding relative integrated intensities being 5:1: 3. The n.m.r. spectrum of I-phenylpropan-2-one, C6Hs0 CH2 0CO1CH3, has been recorded (Sadtler Research Laboratories, 1966) , the X values being 2.8 (phenyl), 6.42 (CH2) and 7.98 (C03) and the corresponding intensities being 5: 2: 3. The n.m.r. spectrum of 1-phenylprop-1 -ene, C6Hs 0*CH: CH 0 CH3, was recorded for us, but the interpretation was rendered difficult since the compound was a mixture of ci8 and trans isomers. However, the doublet with T values 8.25 and 8.35 due to the C03 in the system =CH.CH3 was obvious. A little of compound X was methylated in methanol with diazomethane and the product subjected to mass spectrometry. There was a very small peak at m/e 227, which could correspond to the molecular ion, 06H5 0 CH: C(O S03CH02) .1CH3. According to Reisch, Pagnucco, Alfes, Jantos & Mollmann (1968) , who studied the mass spectra of a number of phenylalkylamines including amphetamine, the molecular ion of these compounds either does not appear or is very small in amount. Attempts to synthesize the enol sulphate of I-phenylpropan-2-one have so far been unsuccessful, so that further support for the tentative structure suggested for compound X is not yet forthcoming. However, Roy (1960) has postulated the formation of 17-enol sulphates of steroids to account for the increased rate of synthesis in the presence of certain 17-oxo steroids of 2-naphthyl sulphamate from 2-naphthylamine in rat liver preparations. Such enol sulphates could behave as 'active sulphate'.
(+)-and (-)-Amphetamine show different pharmacological properties. The acute toxicity of (+)-amphetamine in mice is about ten times that of the (-)-isomer (Fairchild & Alles, 1967) and it is possible that a difference in the metabolic fate of the isomers might be involved in the difference in pharmacological activity. It has been reported that in man and the rat more of the (-)-isomer is excreted unchanged than the (+)-isomer when the (+)-isomer is administered (Gunne, 1967; Gunne & Galland, 1967) . Our results in man (Table 3) show that during the first 24h after dosing, the amount of amphetamine excreted unchanged is about the 434 1970 Vol. 116 
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same for both optically active isomers when given separately. The differences may not be significant in rat, mouse and guinea pig, for the rat excretes in 48h slightly more (-)-isomer than (+)-isomer, whereas the mouse and guinea pig excrete in 24h slightly more (+)-than (-)-amphetamine. More 4-hydroxyamphetamine is excreted after (-)-amphetamine administration in man (Table 3) , rat and mouse (Table 6) , whereas in the guinea pig 4-hydroxyamphetamine was detected in the urine only after dosing with (-)-amphetamine (Table 6 ). This could mean that (-)-amphetamine is more readily 4-hydroxylated than (+)-amphetamine, or that both isomers are 4-hydroxylated equally well, but that the 4-hydroxyamphetamine formed from (+)-amphetamine is more readily further metabolized than that from (-)-amphetamine. It is known that (+)-4-hydroxyamphetamine but not its (-)-isomer is a substrate for the dopamine f-hydroxylase of the rat (Goldstein & Anagnoste, 1965) . Since 4-hydroxyamphetamine is a major metabolite in the rat, but not in other species, further metabolites of 4-hydroxyamphetamine might be more likely to be found in the rat than the other species. This point, however, has not been investigated, although 4-hydroxynorephedrine has been found as a minor metabolite in the urine of the rat (Table 6 ), but other species were not examined. This paper shows that there are wide species variations in the metabolism of amphetamine, but these variations cannot be correlated with any possible species variations in the activity of the drug, since no reliable information on this point is available, except that the drug appears to be more toxic to the rat and mouse than to the rabbit (see Spector, 1956 ).
